1 active not recruiting, 1 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
Follow Plx3397: new trials by email Literature Review of Plx3397 trials Research Report on Plx3397
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT Pexidartinib - Tenosynovial Giant Cell Tumor | Phase 3 | Active not recruiting | Daiichi Sankyo Co., Ltd. | 40 | 2020-09-25 | 2026-06-26 |
| Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS) Pexidartinib, Placebo - Pigmented Villonodular Synovitis, Giant Cell Tumors of the Tendon Sheath | Phase 3 | Completed | Daiichi Sankyo | 120 | 2015-05-11 | 2022-05-11 |
Giant Cell Tumor of Tendon Sheath (2) · Synovitis, Pigmented Villonodular (1)
Daiichi Sankyo (1) · Daiichi Sankyo Co., Ltd. (1)
Australia (1) · Canada (1) · China (1) · Denmark (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Netherlands (1) · Poland (1) · Spain (1) · Taiwan (1) · United Kingdom (1) · United States (1)
PMID 27041409, PMID 31229240, PMID 32755241, PMID 33289960, PMID 36001000, PMID 40841499, PMID 42132251
2014 (1)